1. Home
  2. NOTV vs NOTE Comparison

NOTV vs NOTE Comparison

Compare NOTV & NOTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NOTV
  • NOTE
  • Stock Information
  • Founded
  • NOTV 1974
  • NOTE 2013
  • Country
  • NOTV United States
  • NOTE United States
  • Employees
  • NOTV N/A
  • NOTE N/A
  • Industry
  • NOTV Biotechnology: Pharmaceutical Preparations
  • NOTE EDP Services
  • Sector
  • NOTV Health Care
  • NOTE Technology
  • Exchange
  • NOTV Nasdaq
  • NOTE Nasdaq
  • Market Cap
  • NOTV 137.5M
  • NOTE 133.5M
  • IPO Year
  • NOTV 1997
  • NOTE N/A
  • Fundamental
  • Price
  • NOTV $2.21
  • NOTE $0.81
  • Analyst Decision
  • NOTV Strong Buy
  • NOTE Strong Buy
  • Analyst Count
  • NOTV 3
  • NOTE 6
  • Target Price
  • NOTV $5.92
  • NOTE $2.80
  • AVG Volume (30 Days)
  • NOTV 552.5K
  • NOTE 1.9M
  • Earning Date
  • NOTV 05-09-2025
  • NOTE 03-13-2025
  • Dividend Yield
  • NOTV N/A
  • NOTE N/A
  • EPS Growth
  • NOTV N/A
  • NOTE N/A
  • EPS
  • NOTV N/A
  • NOTE 0.07
  • Revenue
  • NOTV $475,114,000.00
  • NOTE $120,266,000.00
  • Revenue This Year
  • NOTV $6.37
  • NOTE N/A
  • Revenue Next Year
  • NOTV $5.74
  • NOTE $42.32
  • P/E Ratio
  • NOTV N/A
  • NOTE $11.86
  • Revenue Growth
  • NOTV N/A
  • NOTE N/A
  • 52 Week Low
  • NOTV $1.23
  • NOTE $0.75
  • 52 Week High
  • NOTV $11.20
  • NOTE $2.07
  • Technical
  • Relative Strength Index (RSI)
  • NOTV 35.56
  • NOTE 32.20
  • Support Level
  • NOTV $2.72
  • NOTE $0.93
  • Resistance Level
  • NOTV $3.35
  • NOTE $1.08
  • Average True Range (ATR)
  • NOTV 0.31
  • NOTE 0.09
  • MACD
  • NOTV -0.03
  • NOTE -0.01
  • Stochastic Oscillator
  • NOTV 16.79
  • NOTE 2.02

About NOTV Inotiv Inc.

Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery, development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, the company supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, biotherapeutics, and biomedical devices. Through the RMS segment, the company offers access to a wide range of small and large research models for basic research, drug discovery, development, and specialized models for specific diseases and therapeutic areas. The company earns maximum revenue from RMS Segment.

About NOTE FiscalNote Holdings Inc.

FiscalNote Holdings Inc is a provider of global policy and market intelligence solutions. Leveraging AI and analytics, it delivers actionable legal and policy insights for businesses, government institutions, and nonprofits. Its suite of products includes FiscalNote Core, CQ Federal, and EU Issue Tracker, facilitating effective policy management and risk mitigation. With expert analysis from FrontierView, Oxford Analytica, and Dragonfly Eye, it offers geopolitical and market intelligence services. Operating as one segment, it generates revenue by integrating policy intelligence into daily operations. Geographically the company generates the majority of its revenue from North America, Europe, Australia, and Asia, with the majority generated from North America.

Share on Social Networks: